● Company · HealthTech
BioStack Platforms
Healthcare AI data infrastructure company structuring de-identified longitudinal patient records, medical imaging and other clinical data into multimodal datasets and reinforcement-learning environments for medical AI and drug discovery.
Total raised
$9.5M
across 1 round
Valuation
$63.3M
estimated (modeled)
Investors
8
unique backers
Employees
—
reported
Cadence
—
single round only
Funding history
Latest: $9.5M Seed on Oct 22, 2026.
1 round · $9.5M
Oct 22, 2026
$9.5M
Seed · latest
BioStack announced $9.5M seed financing for its clinical-data infrastructure and multimodal training datasets for medical AI, spanning de-identified healthcare records and reinforcement-learning environments. The company announcement lists Peak XV Partners, Afore Capital, DCVC, Emerson Collective, SV Angel, Verdict Capital, Streamlined Ventures and Y Combinator as investors. The release refers to the investor group as leading the round without clearly disaggregating lead status across all eight.
Led by Peak XV Partners
Afore Capital · DCVC · Emerson Collective · SV Angel · Streamlined Ventures · Verdict Capital · Y Combinator
Investors
8 unique.
Detected tech stack
From public scans of getbiostack.com.
Other
Near peers
Companies at a comparable stage and sector.
Undisclosed Stage · Health AI,Health Tech,HealthTech,Healthcare,Healthcare Data,SaaS · May 28, 2026
Series A · AI Agents,Artificial Intelligence,Biotechnology,Life Sciences Software · Sep 15, 2026
Series B · Health AI,Health Tech,Artificial Intelligence,Healthcare IT · Jun 24, 2026